Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amicus Therapeutics Inc. buy Cantor Fitzgerald

Start price
€9.75
18:30 / 50%
Target price
€17.90
20.09.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 20.09.25. The prediction end date can be changed by Cantor_Fitzgerald at any time.
Performance without dividends (%)
Name 1w
Amicus Therapeutics Inc. -
iShares Core DAX® 2.291%
iShares Nasdaq 100 1.336%
iShares Nikkei 225® 1.132%
iShares S&P 500 1.272%

Comments by Cantor_Fitzgerald for this prediction

In the thread Amicus Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 17.898
Change
Ends at 20.09.25

Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
29.02.24
€20.36
28.02.25
-17.37%
19.09.24